Renflexis 100 MG vials
Ended Awarded
- Contract number
- SPE2DB25FC7A3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,472
Award facts
- Contract value 100% obligated
- $35,471.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $35,471.87 to AmerisourceBergen Drug Corp for the supply of Renflexis 100 mg vials. This competitively awarded, firm fixed-price contract was executed on June 4, 2025, with an ultimate completion date of June 5, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Renflexis is a biosimilar medication used to treat various inflammatory conditions and represents part of the pharmaceutical product portfolio that the Defense Logistics Agency procures to support military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen maintains an extensive portfolio of federal contracts supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DB25FC7A3?
SPE2DB25FC7A3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 4, 2025.
How much is contract SPE2DB25FC7A3 worth?
The government has obligated $35,472 on SPE2DB25FC7A3.
Is contract SPE2DB25FC7A3 an order under another contract?
Yes. SPE2DB25FC7A3 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FC7A3 competed?
The extent of competition for SPE2DB25FC7A3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award